Literature DB >> 24434562

Determination of 8-iso-prostaglandin F(2α) (8-iso-PGF(2α)) in human urine by ultra-performance liquid chromatography-tandem mass spectrometry.

S Noble1, D Neville2, R Houghton2.   

Abstract

A rapid, simple and sensitive method was developed for the determination of 8-iso-PGF2α in urine using ultra performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS); 8-iso-PGF2α-d4 was used as the internal standard (IS). Chromatographic separation was performed using an Acquity BEH C18 column with a mobile phase composition of A: 0.1% acetic acid in methanol:acetonitrile (1:1, v:v) and B: 0.1% acetic acid in water (A:B, 32.5:67.5, v:v). Detection was performed on a triple-quadrupole tandem mass spectrometer using atmospheric pressure chemical ionization (APCI) in negative mode and using multiple reaction monitoring (MRM). The MS/MS ion transitions monitored were m/z 353→193 and 357→197 for 8-iso-PGF2α and IS, respectively. The calibration curve was prepared in PBS buffer because of the presence of endogenous concentrations of analyte in the control matrix; the internal standard successfully correcting for matrix effects. Good linearity was observed over the concentration range of 0.025-20 ng/mL; the method proving to be accurate and reliable was successfully used in support of a pharmacodynamic study in humans.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  8-Iso-PGF(2α); Analytical validation; Biomarker; Pharmacodynamics; UPLC–MS/MS; Urine

Mesh:

Substances:

Year:  2013        PMID: 24434562     DOI: 10.1016/j.jchromb.2013.12.028

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  2 in total

1.  Phase separation liquid-liquid extraction for the quantification of 8-iso-Prostaglandin F2 Alpha in human plasma by LC-MS/MS.

Authors:  Desislav G Tomov; Georgeta Bocheva; Vidka Divarova; Lilia Kasabova; Dobrin Svinarov
Journal:  J Med Biochem       Date:  2021-01-26       Impact factor: 3.402

2.  Influence of Diosmin Treatment on the Level of Oxidative Stress Markers in Patients with Chronic Venous Insufficiency.

Authors:  Marcin Feldo; Michał Woźniak; Magdalena Wójciak-Kosior; Ireneusz Sowa; Agata Kot-Waśik; Justyna Aszyk; Jacek Bogucki; Tomasz Zubilewicz; Anna Bogucka-Kocka
Journal:  Oxid Med Cell Longev       Date:  2018-08-28       Impact factor: 6.543

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.